TPIDB > Principal Investigator
Principal Investigator
更新時間：2023-09-19
鄭惠禎Cheng, Hui-Chen
- Co-Principal Investigator
- Clinical Trial Experience (year)
-
hccheng7@vghtpe.gov.tw
Publication
27Publications
21
Yeh HJ, Chen TA, Cheng HC, et al. Long-Term Rehabilitation Utilization Pattern Among Stroke Patients Under the National Health Insurance Program. Am J Phys Med Rehabil 2022;101:129-34
22
Wu RY, Sung WH, Cheng HC, Yeh HJ. Investigating the rate of skeletal muscle atrophy in men and women in the intensive care unit: a prospective observational study. Sci Rep. 2022;12(1):16629.
23
Cheng HC, Chi SC, Liang CY, Yu JY, Wang AG. Candidate Modifier Genes for the Penetrance of Leber's Hereditary Optic Neuropathy. Int J Mol Sci. 2022;23(19).
24
Hung WC, Cheng HC, Wang AG. Melanoma-associated retinopathy with anti-TRPM1 autoantibodies showing concomitant Off-bipolar cell dysfunction. Doc Ophthalmol. 2022;145(3):263-70.
25
Yeh TC, Cheng HC#, Li HY, Chi SC, Yang HY, Yu JY, et al. Ophthalmic characteristics and retinal vasculature changes in Williams syndrome, and its association with systemic diseases. Eye (Lond). 2023;37:2265-2271..( #co-first author)
26
Chi SC, Cheng HC#, Wang AG. Leber Hereditary Optic Neuropathy: Molecular Pathophysiology and Updates on Gene Therapy. Biomedicines. 2022;10(8). (#co-first author)
27
Yeh TC, Niu DM, Cheng HC, Chen YR, Chen LZ, Tsui SP, et al. Novel mutation of IFT140 in an infant with Mainzer-Saldino syndrome presenting with retinal dystrophy. Mol Genet Metab Rep. 2022;33:100937.
